91AV

Mimica is creating the next generation of food expiry labelling that reduces food waste and improves food safety. In the UK, seven million tonnes of food and drink are thrown away annually, costing the average UK household £470 a year. Mimica Touch is designed to tell if food is still fresh, so more money could be saved, and less waste created.

Exscientia is an AI-driven pharma tech company committed to discovering and designing the best possible medicines in the fast-est and most effective manner. Exscientia is the first company to progress AI-designed small molecules into the clinical setting and repeatedly demonstrate the ability of AI to transform how drugs are created. Exscientia’s AI platform has now designed two drugs that are in Phase 1 human clinical trials.

Owlstone Medical have set out to save 100,000 lives and $1.5B in healthcare costs. They have developed Breath Biopsy® OMNI, an end-to-end optimised service for consistent breath collection and analysis, that aims to enable non-invasive early detection of disease and monitoring of treatment response for diseases such as cancer, liver disease, respiratory diseases and many more.

Oxford PV has developed perovskite, a new affordable solar cell material that can convert significantly more energy from sunlight than existing silicon-based solar cells. It delivers more power per square metre which is criti­cal in accelerating the adoption of clean energy in our homes and businesses.

Echion Technologies develops advanced lithium-ion battery materials. They have developed a product that requires only a six-minute charge, is inherently safe compared to present systems, and has a ten-fold increased lifetime over that of a standard lithium-ion cell. Their products contribute to the ambitions for zero emission vehicles by enabling cell manufacturers to deliver cost-effec­tive, fast-charging, high-energy density, and long-life power cells.

ViridiCO2 Ltd developed technology, known as Carbon Capture Utilisation (CCU). It transforms high volume waste carbon dioxide gas emissions from es­tablished chemical manufacturers and foundation industries – such as steel and cement – into high value carbon-based chemicals and feedstocks which can be found in everyday items such as furniture or batteries.

HexagonFab, a fast-growing biotech company, has developed Bolt, a portable analysis tool containing a graphene composite sensor that will accelerate drug research and manufacturing. This platform technology has potential applica­tions in diagnostics and industrial monitoring. Their technology will lead to new treatments and diagnostics and the successful large-scale manufacture of this nanomaterial will pave the way for an entire generation of new technologies.

The COVID-19 pandemic has highlighted the importance of viral and bacterial surveillance. Iceni Glycoscience’s novel technology could be critical in the response to future disease outbreaks. This innovative company is developing diagnostic technologies and treatments for infectious diseases using proprie­tary technology based on carbohydrate chemistry.